Kenfarb & Co. Amgen Inc Transaction History

Kenfarb & Co.

$108 Million
Q3 2023

A detailed history of Kenfarb & Co. transactions in Amgen Inc stock. As of the latest transaction made, Kenfarb & Co. holds 4,685 shares of AMGN stock, worth $1.23 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

4,685

Previous 4,735 1.06%

Holding current value

$1.23 Million

Previous $1.05 Million 19.79%

% of portfolio

1.16%

Previous 0.92%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $10,932 - $13,572	-50 Reduced 1.06%	4,685 $1.26 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $49,282 - $58,275	-230 Reduced 4.63%	4,735 $1.05 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $51,931 - $63,296	-230 Reduced 4.43%	4,965 $1.2 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $6,870 - $8,730	-30 Reduced 0.57%	5,195 $1.36 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.04 Million - $1.19 Million	5,225 New	5,225 $1.18 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kenfarb & Co., based on Form 13F filings with the SEC.

News

Stay updated on Kenfarb & Co. with notifications on news.

Account